Marc A. Began
General Counsel, AbioMed.
Companies
- Axogen, Inc.General counsel Mar 30, 2023 to now1
- AbioMedGeneral counsel Aug 25, 2020 to Dec 27, 20222
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Axogen, Inc. AXGN50,135 shares3$1.7M at $34.55Aug 10, 2026
AbioMed ABMD0 shares4Dec 22, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 10, 2026Sold 67,500 shares at $47.35 of Axogen, Inc.3
- Aug 10, 2026Exercised options 67,500 shares at $8.16 of Axogen, Inc.3
- Mar 1, 2026Shares withheld for tax 4,427 shares at $30.65 of Axogen, Inc.5
- Mar 1, 2026Exercised options 11,250 shares of Axogen, Inc.5
- Feb 26, 2026Shares withheld for tax 8,753 shares at $31.90 of Axogen, Inc.5
- Feb 26, 2026Granted 33,780 shares of Axogen, Inc.5
- Dec 11, 2025Sold 13,222 shares at $30.00 of Axogen, Inc.6
- Dec 9, 2025Sold 9,278 shares at $31.21 of Axogen, Inc.7
- Dec 4, 2025Granted 22,500 shares of Axogen, Inc.8
- Mar 4, 2025Shares withheld for tax 5,901 shares at $18.36 of Axogen, Inc.9
- Mar 1, 2025Exercised options 22,500 shares of Axogen, Inc.9
- Feb 25, 2025Shares withheld for tax 814 shares at $16.50 of Axogen, Inc.10
- Feb 22, 2025Granted 2,500 shares of Axogen, Inc.10
- Dec 22, 2022Returned to company 12,237 shares of AbioMed4
- Nov 5, 2022Shares withheld for tax 1,548 shares at $373.99 of AbioMed11
- Nov 4, 2022Sold 2,000 shares at $373.71 of AbioMed11
- Aug 29, 2022Sold 500 shares at $255.95 of AbioMed12
- May 29, 2022Shares withheld for tax 480 shares at $266.34 of AbioMed13
- May 29, 2022Shares withheld for tax 976 shares at $266.34 of AbioMed13
- May 29, 2022Granted 2,200 shares of AbioMed13
- May 26, 2022Granted 4,680 shares of AbioMed13
- May 25, 2022Shares withheld for tax 298 shares at $249.19 of AbioMed14
- Nov 6, 2021Shares withheld for tax 152 shares at $361.71 of AbioMed15
- Nov 3, 2021Shares withheld for tax 1,549 shares at $349.76 of AbioMed16
- Nov 3, 2021Granted 6,975 shares of AbioMed16
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAxogen, Inc., General counsel
- 2SEC EDGARAbioMed, General counsel
- 3
- 4
- 5SEC EDGARForm 4 filed Mar 2, 2026
- 6SEC EDGARForm 4 filed Dec 12, 2025
- 7SEC EDGARForm 4 filed Dec 10, 2025
- 8SEC EDGARForm 4 filed Dec 5, 2025
- 9SEC EDGARForm 4 filed Mar 5, 2025
- 10SEC EDGARForm 4 filed Feb 26, 2025
- 11SEC EDGARForm 4 filed Nov 8, 2022
- 12SEC EDGARForm 4 filed Aug 30, 2022
- 13SEC EDGARForm 4 filed May 31, 2022
- 14SEC EDGARForm 4 filed May 27, 2022
- 15SEC EDGARForm 4 filed Nov 9, 2021
- 16SEC EDGARForm 4 filed Nov 5, 2021